Details of the Drug Metabolized by Drug-Metabolizing Enzyme (DME)

General Information of Drug (ID: DR5412)
Drug Name
Arsenic trioxide
Synonyms
Arsenox; Arsentrioxide; Naonobin; Trisenox; Trixenox; Acide arsenieux [French]; Anhydride arsenieux [French]; Arseni trioxydum; Arsenic blanc [French]; Arsenic trioxide [JAN]; Arsenigen saure [German]; Arsenious Acid Anhydride; Arsenious trioxide; Arsenous oxide [ISO]; Oxyde Arsenieux; Arsenic trioxide [UN1561] [Poison]; Arsenic oxide (As2O3); Arsenic(III) trioxide; Oxyde Arsenieux [ISO-French]; Trisenox (TN); Arsenic trioxide (JP15/USAN); Arsenic(3+)
Indication Mantle cell lymphoma [ICD11: 2A85] Approved [1]
Structure
3D MOL 2D MOL
Pharmaceutical Properties Molecular Weight 197.841 Topological Polar Surface Area 3
Heavy Atom Count 5 Rotatable Bond Count 0
Hydrogen Bond Donor Count 0 Hydrogen Bond Acceptor Count 3
Cross-matching ID
PubChem CID
14888
CAS Number
1327-53-3
TTD Drug ID
D07VIK
Formula
As2O3
Canonical SMILES
[O-2].[O-2].[O-2].[As+3].[As+3]
InChI
InChI=1S/2As.3O/q2*+3;3*-2
InChIKey
QTLQKAJBUDWPIB-UHFFFAOYSA-N
The Metabolic Roadmap of This Drug
The Full List of Drug Metabolites (DM) of This Drug
DM Name DM ID PubChem ID Reaction DM Level REF
Arsenous acid (AsIII) DM014817
545
Hydrolysis - Hydrolysis 1 [2]
Arsenic acid (AsV) DM014808
234
Conjugation - O-methylation 2 [2]
Monomethylarsonic acid(MMAV) DM001751
8948
Conjugation - O-methylation 2 [3] , [4] , [2]
Dimethylarsinic acid (DMAV) DM001752
2513
Conjugation - O-methylation 3 [3] , [4] , [2]
The Full List of Metabolic Reaction (MR) of This Drug
MR ID Reactant Product MR Type DME REF
MR012721 Arsenic trioxide Arsenous acid (AsIII) Hydrolysis - Hydrolysis Unclear [2]
MR012722 Arsenous acid (AsIII) Monomethylarsonic acid(MMAV) Conjugation - O-methylation AS3MT [3], [4], [2]
MR012724 Arsenous acid (AsIII) Arsenic acid (AsV) Conjugation - O-methylation Unclear [2]
MR012723 Monomethylarsonic acid(MMAV) Dimethylarsinic acid (DMAV) Conjugation - O-methylation AS3MT [3], [4], [2]
References
1 FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 078729.
2 LABEL:ARSENIC TRIOXIDE injection
3 Type 2 diabetes affects arsenic metabolism via transporters in arsenic trioxide treated acute promyelocytic leukemia patients
4 Biotransformation of arsenic trioxide by AS3MT favors eradication of acute promyelocytic leukemia: revealing the hidden facts

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.